Location: Philadelphia, PA
Contact: 434 W. Foothill Blvd Monrovia, CA 91016

Trial costs are spiraling as trials are getting bigger and more expensive to run. Major drug manufacturers lose millions when their drug candidates are pulled in late stage clinical trials. Meanwhile, the FDA is developing non-binding guidance papers that encourage drug companies to design and implement "adaptive designs" for clinical trials.

Pharma and Biotech companies seem to be willing to roll out trials using targeted designs because it allows them to make earlier decisions, lower drug development costs and reduce the time it takes to bring a drug to market. In fact, each of the FDA`s drug evaluation branches already report having received such trial proposals from pharmaceutical and biotech sources.

Official Site